title: Kynurenine pathway metabolites and suicidality.
abstract: Suicide is a major global problem, claiming more than 800,000 lives annually. The neurobiological changes that underlie suicidal ideation and behavior are not fully understood. Suicidal patients have been shown to display elevated levels of inflammation both in the central nervous system and the peripheral blood. A growing body of evidence suggests that inflammation is associated with a dysregulation of the kynurenine pathway in suicidal patients, resulting in an imbalance of neuroactive metabolites. Specifically, an increase in the levels of the NMDA receptor agonist quinolinic acid and a simultaneous decrease in neuroprotective metabolites have been observed in suicidal patients, and may contribute to the development of suicidality via changes in glutamate neurotransmission and neuroinflammation. The cause of the dysregulation of kynurenine metabolites in suicidality is not known, but is likely due to differential activity of the involved enzymes in patients. As knowledge in these areas is rapidly growing, targeting the kynurenine pathway enzymes may provide novel therapeutic approaches for managing suicidal behavior. This article is part of the Special Issue entitled 'The Kynurenine Pathway in Health and Disease'.
authors.affiliation: Laboratory of Behavioral Medicine, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA.
authors.forename: Elena Y
authors.initials: EY
authors.lastname: Bryleva
authors.affiliation: Laboratory of Behavioral Medicine, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA. Electronic address: Lena.Brundin@vai.org.
authors.forename: Lena
authors.initials: L
authors.lastname: Brundin
mesh_terms: D000818:Animals; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000378:metabolism; D007737:Kynurenine / Q000378:metabolism*; D053858:Metabolic Networks and Pathways / Q000502:physiology*; D013405:Suicide
chemical_list: D016207:Cytokines; D007737:Kynurenine
keywords: Cytokine; Depression; Glutamate; Inflammation; Kynurenine pathway; Quinolinic acid
references.citation: Neuroreport. 1997 Jan 20;8(2):431-4
references.pmid: 9080423
references.citation: Trends Pharmacol Sci. 2013 Feb;34(2):136-43
references.pmid: 23123095
references.citation: J Affect Disord. 2007 Feb;98(1-2):143-51
references.pmid: 16952400
references.citation: Neurotoxicol Teratol. 2011 Sep-Oct;33(5):538-47
references.pmid: 21763768
references.citation: Eur Psychiatry. 2012 Feb;27(2):129-41
references.pmid: 22137775
references.citation: Am J Geriatr Psychiatry. 2014 Oct;22(10):989-96
references.pmid: 24731781
references.citation: Biochemistry. 2000 Jun 20;39(24):7266-75
references.pmid: 10852726
references.citation: Brain Res. 1992 Dec 18;599(1):57-63
references.pmid: 1493549
references.citation: Ann N Y Acad Sci. 2013 Jul;1292:21-31
references.pmid: 23876043
references.citation: Int J Vitam Nutr Res. 2007 Mar;77(2):142-8
references.pmid: 17896587
references.citation: Emerg Med J. 2011 Jun;28(6):467-71
references.pmid: 20660941
references.citation: Brain Behav Immun. 2012 Aug;26(6):979-87
references.pmid: 22683764
references.citation: J Neurosci. 2007 Nov 21;27(47):12884-92
references.pmid: 18032661
references.citation: Am J Clin Nutr. 1971 Jun;24(6):659-72
references.pmid: 4253043
references.citation: J Psychiatry Neurosci. 2015 Mar;40(2):126-33
references.pmid: 25455350
references.citation: Neurochem Res. 2005 Aug;30(8):963-8
references.pmid: 16258845
references.citation: Lancet. 2015 Jan 10;385(9963):117-71
references.pmid: 25530442
references.citation: FEBS J. 2007 Feb;274(3):827-40
references.pmid: 17288562
references.citation: J Psychiatr Pract. 2009 Jul;15(4):282-8
references.pmid: 19625883
references.citation: Amino Acids. 1998;14(1-3):257-61
references.pmid: 9871471
references.citation: Adv Exp Med Biol. 2003;527:155-65
references.pmid: 15206728
references.citation: Nat Rev Neurosci. 2003 Oct;4(10):819-28
references.pmid: 14523381
references.citation: Neuroscience. 1994 Aug;61(3):603-12
references.pmid: 7969932
references.citation: Psychiatry Res. 2013 Jan 30;205(1-2):165-7
references.pmid: 22980480
references.citation: J Child Psychol Psychiatry. 2010 Aug;51(8):935-43
references.pmid: 20406333
references.citation: J Neural Transm (Vienna). 2012 Feb;119(2):133-9
references.pmid: 22215208
references.citation: Biochem J. 1996 Dec 1;320 ( Pt 2):595-7
references.pmid: 8973572
references.citation: J Trace Elem Med Biol. 2015 Jan;29:222-6
references.pmid: 25037773
references.citation: Adv Exp Med Biol. 1996;398:247-54
references.pmid: 8906272
references.citation: Adv Exp Med Biol. 1999;467:389-95
references.pmid: 10721080
references.citation: CNS Drugs. 2015 Mar;29(3):181-8
references.pmid: 25715884
references.citation: Am J Reprod Immunol. 2014 Nov;72(5):496-503
references.pmid: 24974860
references.citation: Am J Psychiatry. 2005 Nov;162(11):2116-24
references.pmid: 16263852
references.citation: J Clin Psychiatry. 1999 Apr;60(4):237-40
references.pmid: 10221284
references.citation: Mol Psychiatry. 2015 Sep;20(9):1057-68
references.pmid: 26169973
references.citation: Brain Behav Immun. 2015 May;46:55-9
references.pmid: 25686798
references.citation: Neurochem Int. 1997 Feb;30(2):233-7
references.pmid: 9017671
references.citation: J Psychiatr Pract. 2005 Sep;11(5):302-14
references.pmid: 16184071
references.citation: J Neuroinflammation. 2011 Aug 10;8:94
references.pmid: 21831269
references.citation: Proc Natl Acad Sci U S A. 1990 Apr;87(7):2506-10
references.pmid: 2320571
references.citation: Toxicol Sci. 2004 Oct;81(2):302-8
references.pmid: 15229365
references.citation: Int J Neuropsychopharmacol. 2011 Sep;14(8):1127-31
references.pmid: 21557878
references.citation: Adv Exp Med Biol. 2003;527:443-53
references.pmid: 15206762
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21
references.pmid: 21185346
references.citation: J Clin Psychiatry. 2003 Sep;64(9):1122-9
references.pmid: 14628990
references.citation: FEBS J. 2012 Apr;279(8):1355
references.pmid: 22251552
references.citation: Biol Psychiatry. 2012 Jun 1;71(11):939-46
references.pmid: 22297150
references.citation: Int J Tryptophan Res. 2009;2:71-9
references.pmid: 22084583
references.citation: Brain Behav Immun. 2015 Jan;43:110-7
references.pmid: 25124710
references.citation: Int J Environ Res Public Health. 2012 Mar;9(3):760-71
references.pmid: 22690161
references.citation: Annu Rev Med. 2015;66:509-23
references.pmid: 25341010
references.citation: Front Hum Neurosci. 2014 Oct 22;8:824
references.pmid: 25374525
references.citation: Psychiatry Res. 2015 Aug 30;228(3):235-42
references.pmid: 26163724
references.citation: Br J Psychiatry. 1997 Mar;170:205-28
references.pmid: 9229027
references.citation: J Chromatogr A. 2013 Nov 5;1316:147-53
references.pmid: 24119749
references.citation: Nat Rev Neurosci. 2012 Jul;13(7):465-77
references.pmid: 22678511
references.citation: Lancet. 2009 Apr 18;373(9672):1372-81
references.pmid: 19376453
references.citation: Mol Psychiatry. 2009 May;14(5):511-22
references.pmid: 18195714
references.citation: J Affect Disord. 2009 Oct;117 Suppl 1:S44-53
references.pmid: 19656575
references.citation: FEBS J. 2012 Apr;279(8):1356-65
references.pmid: 22248144
references.citation: Bipolar Disord. 2006 Oct;8(5 Pt 2):625-39
references.pmid: 17042835
references.citation: Schizophr Bull. 2012 May;38(3):426-32
references.pmid: 20729465
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):37-44
references.pmid: 19778568
references.citation: Neurochem Int. 1996 Apr;28(4):445-52
references.pmid: 8740453
references.citation: J Neurochem. 2011 Sep;118(5):816-25
references.pmid: 21182524
references.citation: Adv Exp Med Biol. 2003;527:105-12
references.pmid: 15206722
references.citation: Neuropsychopharmacology. 2013 Apr;38(5):743-52
references.pmid: 23299933
references.citation: J Affect Disord. 2013 Nov;151(2):679-85
references.pmid: 23992681
references.citation: Int J Tryptophan Res. 2010;3:51-9
references.pmid: 22084587
references.citation: Eur Arch Psychiatry Clin Neurosci. 2015 Jun;265(4):321-9
references.pmid: 25409655
references.citation: CNS Drugs. 2009;23(2):91-101
references.pmid: 19173370
references.citation: J Neurochem. 2001 Aug;78(4):842-53
references.pmid: 11520905
references.citation: Psychopharmacology (Berl). 2014 Sep;231(18):3663-76
references.pmid: 25038867
references.citation: Psychiatry Res. 2015 Jun 30;227(2-3):206-12
references.pmid: 25865484
references.citation: Biol Psychiatry. 2003 Feb 1;53(3):261-4
references.pmid: 12559660
references.citation: Eur Psychiatry. 2010 Jun;25(5):275-7
references.pmid: 20462744
references.citation: Arch Gen Psychiatry. 1976 Oct;33(10):1193-7
references.pmid: 971028
references.citation: J Neurochem. 1990 Sep;55(3):738-44
references.pmid: 2384749
references.citation: J Affect Disord. 2011 Nov;134(1-3):112-8
references.pmid: 21723616
references.citation: Neuropsychopharmacology. 2013 Aug;38(9):1609-16
references.pmid: 23511700
references.citation: J Clin Psychiatry. 2010 Dec;71(12):1605-11
references.pmid: 20673547
references.citation: Biol Psychiatry. 2009 Sep 1;66(5):522-6
references.pmid: 19545857
references.citation: J Clin Psychiatry. 2007 Mar;68(3):380-3
references.pmid: 17388706
references.citation: Suicide Life Threat Behav. 2012 Feb;42(1):1-10
references.pmid: 22320192
references.citation: Biosci Biotechnol Biochem. 2002 Jul;66(7):1435-41
references.pmid: 12224625
references.citation: Brain Behav Immun. 2011 Aug;25(6):1272-8
references.pmid: 21605657
references.citation: J Neurochem. 2009 Mar;108(5):1220-5
references.pmid: 19141084
references.citation: Neuropsychopharmacology. 2012 May;37(6):1526-33
references.pmid: 22298121
references.citation: Psychiatry Res. 2011 Aug 15;188(3):355-60
references.pmid: 21492941
references.citation: J Comp Neurol. 1992 Jul 15;321(3):477-87
references.pmid: 1506481